Eramian Daniel G

CIK 00013558501 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001355850

Recent Transactions

39 trades

Sale
CTI BIOPHARMA CORP
Common Stock
2012-09-20$2.68/sh−15,000→ 354,350 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-08-24$0.39/sh−23,442→ 1,876,761 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-08-24$0.39/sh−41,558→ 1,900,203 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-08-24$0.40/sh−10,000→ 1,846,761 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-08-24$0.39/sh−20,000→ 1,856,761 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.57/sh−6,800→ 1,981,761 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.57/sh−9,731→ 1,972,030 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.58/sh−20,000→ 1,941,761 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.57/sh−3,000→ 1,988,761 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.58/sh−10,000→ 1,961,761 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.57/sh−269→ 1,971,761 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.57/sh−200→ 1,988,561 total
Award
CTI BIOPHARMA CORP
Common Stock
2012-06-27+27,415→ 1,991,761 total
Tax Payment
CTI BIOPHARMA CORP
Common Stock
2012-03-21$1.31/sh−7,593→ 1,964,346 total
Award
CTI BIOPHARMA CORP
Common Stock
2012-01-03+1,211,953→ 1,971,939 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2011-12-31−498,329→ 759,986 total
Award
CTI BIOPHARMA CORP
Common Stock
2011-11-29+505,688→ 1,258,315 total
Tax Payment
CTI BIOPHARMA CORP
Common Stock
2011-09-21$1.02/sh−7,593→ 752,627 total
Tax Payment
CTI BIOPHARMA CORP
Common Stock
2011-03-25$0.38/sh−105,579→ 4,311,320 total
Award
CTI BIOPHARMA CORP
Restricted Stock Units
2011-03-21+250,000→ 250,000 total
Award
CTI BIOPHARMA CORP
Common Stock
2011-03-21+250,000→ 4,666,899 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2010-12-27−8,000→ 4,416,899 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-16$0.36/sh−250,000→ 4,424,899 total
Award
CTI BIOPHARMA CORP
Common Stock
2010-07-12+2,989,983→ 4,674,899 total
Tax Payment
CTI BIOPHARMA CORP
Common Stock
2010-03-25$0.67/sh−105,579→ 1,684,916 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2009-12-31−5,040→ 1,790,495 total
Award
CTI BIOPHARMA CORP
Performance Rights
2009-12-15+1,320,752→ 1,320,752 total
Award
CTI BIOPHARMA CORP
Common Stock
2009-11-10+870,050→ 2,112,668 total
Tax Payment
CTI BIOPHARMA CORP
Common Stock
2009-11-10$0.99/sh−317,133→ 1,795,535 total
Tax Payment
CTI BIOPHARMA CORP
Common Stock
2009-10-22$1.11/sh−27,337→ 1,242,618 total
Sale
CTI BIOPHARMA CORP
Common Stock
2009-09-25$1.25/sh−104,276→ 1,269,955 total
Tax Payment
CTI BIOPHARMA CORP
Common Stock
2009-07-31$1.48/sh−235,064→ 1,374,231 total
Award
CTI BIOPHARMA CORP
Common Stock
2009-07-31+644,897→ 1,609,295 total
Award
CTI BIOPHARMA CORP
Common Stock
2009-07-31+644,897→ 1,609,295 total
Tax Payment
CTI BIOPHARMA CORP
Common Stock
2009-07-31$1.48/sh−235,064→ 964,398 total
Award
CTI BIOPHARMA CORP
Common Stock
2009-03-25+868,967→ 964,398 total
Award
CTI BIOPHARMA CORP
Common Stock
2008-10-22+75,000→ 95,431 total
Award
CTI BIOPHARMA CORP
Common Stock
2006-06-23+15,000→ 55,000 total
Award
CTI BIOPHARMA CORP
Incentive Stock Option (right to buy)
2006-06-22+30,000→ 30,000 total

Companies

CTI BIOPHARMA CORP
EVP, Corporate Communications

Recent Filings

Address

501 ELLIOTT AVE. W. SUITE #400

SEATTLE, WA, 98119

View on SEC.gov